{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:30:16Z","timestamp":1789421416887,"version":"build-2803163510"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Clin Pathol"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1309\/ja1wd8jnvlgynqye","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T16:33:14Z","timestamp":1176913994000},"page":"736-743","source":"Crossref","is-referenced-by-count":34,"title":["<i>JAK2<\/i>V617F Mutation in Patients With Catastrophic Intra-abdominal Thromboses"],"prefix":"10.1093","volume":"127","author":[{"given":"Christine","family":"McMahon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Abu-Elmagd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin A.","family":"Bontempo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Kant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,5,1]]},"reference":[{"key":"E00001","unstructured":"Menon KVN, Shah V, Kamath P. The Budd-Chiari syndrome. <i>N Engl J Med.<\/i> 2004;350:578-585."},{"key":"E00002","unstructured":"Kumar S, Sarr MG, Kamath P. Mesenteric venous thrombosis. <i>N Engl J Med.<\/i> 2001;345:1683-1688."},{"key":"E00003","unstructured":"Briere J. Budd-Chiari syndrome and portal vein thrombosis associated with myeloproliferative disorders: diagnosis and management. <i>Semin Thromb Hemost.<\/i> 2006;32:208-218."},{"key":"E00004","unstructured":"Chait Y, Condat B, Cazals-Hatem D, et al. Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis. <i>Br J Haematol.<\/i> 2005;129:553-560."},{"key":"E00005","unstructured":"Melear JM, Goldstein RM, Levy MF, et al. Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders. <i>Transplantation.<\/i> 2002;74:1090-1095."},{"key":"E00006","unstructured":"Valla D, Casadevall N, Lacombe C, et al. Primary myeloproliferative disorder and hepatic vein thrombosis: a prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. <i>Ann Intern Med.<\/i> 1985;103:329-334."},{"key":"E00007","unstructured":"Anger BR, Seifried E, Scheppach J, et al. Budd-Chiari syndrome and thrombosis of other abdominal vessels in the chronic myeloproliferative diseases. <i>Klin Wochenschr.<\/i> 1989;67:818-825."},{"key":"E00008","unstructured":"Regev A, Stark P, Blickstein D, et al. Thrombotic complications of essential thrombocythemia with relatively low platelet counts. <i>Am J Hematol.<\/i> 1997;56:168-172."},{"key":"E00009","unstructured":"De Stefano V, Teofili L, Leone G, et al. Spontaneous erythroid colony formation as the clue to an underlying myeloproliferative disorder in patients with Budd-Chiari syndrome or portal vein thrombosis. <i>Semin Thromb Hemost.<\/i> 1997;23:411-418."},{"key":"E00010","unstructured":"McNamara C, Juneja S, Wolf M, et al. Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts. <i>Clin Lab Haematol.<\/i> 2002;24:239-242."},{"key":"E00011","unstructured":"Patel RK, Lea NC, Heneghan MA, et al. Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. <i>Gastroenterology.<\/i> 2006;130:2031-2038."},{"key":"E00012","unstructured":"Thurmes PJ, Steensma DP. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of <i>JAK2<\/i> mutation analysis. <i>Eur J Haematol.<\/i> 2006;77:57-60."},{"key":"E00013","unstructured":"Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. <i>Lancet.<\/i> 2005;365:1054-1061."},{"key":"E00014","doi-asserted-by":"crossref","unstructured":"James C, Ugo V, Le Couedic JP, et al. A unique clonal <i>JAK2<\/i> mutation leading to constitutive signalling causes polycythaemia vera. <i>Nature<\/i>. 2005;434:1144-1148.","DOI":"10.1038\/nature03546"},{"key":"E00015","unstructured":"Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of <i>JAK2<\/i> in myeloproliferative disorders. <i>N Engl J Med.<\/i> 2005;352:1779-1790."},{"key":"E00016","unstructured":"Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. <i>Cancer Cell.<\/i> 2005;7:387-397."},{"key":"E00017","unstructured":"Jones AV, Kreil S, Zoi K, et al. Widespread occurrence of the <i>JAK2<\/i> V617F mutation in chronic myeloproliferative disorders. <i>Blood.<\/i> 2005;106:2162-2168."},{"key":"E00018","unstructured":"Zhao R, Xing S, Li Z, et al. Identification of an acquired <i>JAK2<\/i> mutation in polycythemia vera. <i>J Biol Chem.<\/i> 2005;280:22788-22792."},{"key":"E00019","unstructured":"Jelinek J, Oki Y, Gharibyan V, et al. <i>JAK2<\/i> mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia. <i>Blood.<\/i> 2005;106:3370-3373."},{"key":"E00020","unstructured":"Giraldo M, Martin D, Colangelo J, et al. Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. <i>Transplant Proc.<\/i> 2000;32:1223-1224."},{"key":"E00021","unstructured":"Ridker PM, Miletich JP, Hennekens CH, et al. Ethnic distributions of factor V Leiden in 4047 men and women: implications for venous thromboembolism screening. <i>JAMA.<\/i> 1997;277:1305-1307."},{"key":"E00022","unstructured":"Poort SR, Rosendaal FR, Reitsma PH, et al. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. <i>Blood.<\/i> 1996;88:3698-3703."},{"key":"E00023","doi-asserted-by":"crossref","unstructured":"Greiner TC. Diagnostic assays for the <i>JAK2<\/i> V617F mutation in chronic myeloproliferative disorders. <i>Am J Clin Pathol.<\/i> 2006;125:651-653.","DOI":"10.1309\/NXXT-GRCX-D0TM-A3C2"},{"key":"E00024","unstructured":"Sidon P, Heimann P, Lambert F, et al. Combined locked nucleic acid and molecular beacon technologies for sensitive detection of the JAK2V617F somatic single-base sequence variant. <i>Clin Chem.<\/i> 2006;52:1436-1438."},{"key":"E00025","unstructured":"Sidon P, El Housni H, Dessars B, et al. The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors [letter]. <i>Leukemia.<\/i> 2006;20:1622."},{"key":"E00026","unstructured":"Falanga A, Marchetti M, Evangelista V, et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. <i>Blood.<\/i> 2000;96:4261-4266."},{"key":"E00027","unstructured":"Falanga A, Marchetti M, Vignoli A, et al. Leukocyte-platelet interaction in patients with essential thrombocythemia and polycythemia vera. <i>Exp Hematol.<\/i> 2005;33:523-530."},{"key":"E00028","unstructured":"Arellano-Rodrigo E, Alvarez-Larran A, Reverter JC, et al. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the <i>JAK2<\/i> mutational status. <i>Haematologica.<\/i> 2006;91:169-175."},{"key":"E00029","unstructured":"Alvarez-Larran A, Garcia-Pagan JC, Abraldes JG, et al. Increased CD11b neutrophil expression in Budd-Chiari syndrome or portal vein thrombosis secondary to polycythemia vera. <i>Br J Haematol.<\/i> 2004;124:329-335."},{"key":"E00030","doi-asserted-by":"crossref","unstructured":"Harrison CN. Platelets and thrombosis in myeloproliferative diseases. <i>Hematology (Am Soc Hematol Educ Program).<\/i> 2005:409-415.","DOI":"10.1182\/asheducation-2005.1.409"},{"key":"E00031","unstructured":"Falanga A, Marchetti M, Barbui T, et al. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils. <i>Semin Hematol.<\/i> 2005;42:239-247."},{"key":"E00032","unstructured":"Valla D, Casadevall N, Huisse MG, et al. Etiology of portal vein thrombosis in adults: a prospective evaluation of primary myeloproliferative disorders. <i>Gastroenterology.<\/i> 1988;94:1063-1069."},{"key":"E00033","unstructured":"Denninger MH, Chait Y, Casadevall N, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. <i>Hepatology.<\/i> 2000;31:587-591."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajcp\/article-pdf\/127\/5\/736\/4988069\/ajcpath127-0736.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T07:25:05Z","timestamp":1556349905000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article-lookup\/doi\/10.1309\/JA1WD8JNVLGYNQYE"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,5,1]]},"published-print":{"date-parts":[[2007,5]]}},"alternative-id":["10.1309\/JA1WD8JNVLGYNQYE"],"URL":"https:\/\/doi.org\/10.1309\/ja1wd8jnvlgynqye","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}